Quote
334.90
+4.06 (+1.23%)
We have scored 46 news catalysts on COR (COR) over the past 12 months. Coverage across the window leans mixed (average ticker sentiment +0.01). Most of the impact sits in sector healthcare and forward growth expectations.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
329.15–335.83
Open
333.26
Prev close
330.84
Volume
582.7K
Avg volume
—
Dividend
—
IPO
—
No scored news tagged COR or its network in the window yet.
Show more COR articles →Analysts publish price targets on COR, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
6 analyst price targets from $330 to $430
as of 2026-09-13
The market is 8% below the median target — more cautious than the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about COR — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for COR: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The price sits at the very bottom of the published model range, 8% below the median target, meaning the market has fully absorbed the lowered revenue guidance and refuses to pay for any recovery or margin upside.
What the disagreement turns on
Whether pharmaceutical distribution unit volumes can grow fast enough to offset the manufactured list price reductions and push revenue growth back toward 7% or higher, which the wired data can measure via segment revenue history but cannot confirm without pricing data.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $322 on 2026-09-13 — 51 days ago.
